Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

European shares gain on vaccine hopes, Atlantia soars

Published 07/15/2020, 03:44 AM
Updated 07/15/2020, 04:55 AM
© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt

By Sruthi Shankar

(Reuters) - European shares rebounded on Wednesday from losses in the previous session following reports of progress in developing a COVID-19 vaccine, but a mixed bag of quarterly earnings reports capped gains.

The pan-European STOXX 600 (STOXX) rose 0.9%, with growth-sensitive sectors such as travel & leisure (SXTP), miners (SXPP) and industrial companies (SXNP) leading gains.

Market sentiment got a boost after U.S. biotech firm Moderna Inc's (O:MRNA) experimental vaccine for COVID-19 showed it was safe and provoked immune responses in an ongoing early-stage study.

"We have quite an optimistic mood in the market based on not-too-bad earnings reports and the forward-looking optimism about a vaccine," UniCredit's lead equity sector strategist Christian Stocker said.

"This is why cyclical stocks are up today."

As Europe Inc starts churning out trading updates that are expected to show a more than 50% dive, on average, in second-quarter profits, investors are keen to see whether the market bounce back can be sustained.

Swedish telecom operator Tele2 AB (ST:TEL2b) gained 3.7% as it reaffirmed its 2020 earnings outlook and plans for an extra shareholder payout.

The world's largest fish farmer Mowi ASA (OL:MOWI) jumped 6.4% as harvest volumes beat its own forecast. Shares in peer Salmar (OL:SALM) rose 3%.

The top gainer on the STOXX 600 was Atlantia SpA (MI:ATL), which shot up 22.5% after the Italian infrastructure group and its unit Autostrade made the government new offers to settle their long-running dispute.

Under the offer, Italy's state lender Cassa Depositi e Prestiti (CDP) will take a majority stake in Autostrade and the company will be spun off and listed.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Hopes were high among investors heading into a EU summit later this week that leaders will agree on a recovery fund of 750 billion euros for pandemic-hammered economies.

The European Central Bank also starts a two-day meeting although no major announcements are expected when it concludes on Thursday.

Semiconductor equipment maker ASML Holding NV (AS:ASML) slipped 0.6% as it reported quarterly profit below estimates, but forecast overall growth for 2020.

Swedish bank SEB AB (ST:SEBa) fell 2.4% after reporting a smaller-than-expected fall in net quarterly profit, but credit loss provisions surged. Handelsbanken AB (ST:SHBa) also dropped 1.6%.

In UK, fashion brand Burberry Group (L:BRBY) declined 5.5% as it warned second-quarter revenue will remain impacted by the pandemic, but ASOS (L:ASOS) rose 2.8% as it forecast annual profit towards the top end of expectations.

Latest comments

always HOPES
always HOPES
Why continue bidding up super overvalued US stocks when there are plenty of European and Asian blue chips that are still 20-30% below their pre-Covid highs? Go to safety.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.